感染新型冠状病毒后择期关节置换手术时机决策的系统综述
该研究系统检索了PubMed(MEDLINE)、Excerpta Medica数据库和专业学会网站,共纳入14项研究和专业学会指南,探讨术前新型冠状病毒检测阳性后择期关节置换手术的最佳重新安排时间。结论认为应根据患者症状严重程度设定不同时间框架,并推荐多学科、以患者为中心的方法重新安排手术,需进一步研究新变异株和疫苗接种对时间框架的影响。
要点
- 无症状新型冠状病毒感染者应在检测阳性后4-8周重新安排手术,期间未出现症状。
- 轻/中度感染者应在检测阳性后6-8周且症状完全缓解后重新安排手术。
- 重/危重症感染者应在出院后至少12周且症状完全缓解后重新安排手术。
核心结论
- 鉴于术前新型冠状病毒感染与术后并发症之间存在负相关,应根据患者症状在不同时间框架内重新安排择期关节置换手术。
- 推荐采用多学科和以患者为中心的方法重新安排患者手术。
- 需要进一步研究探讨新型新型冠状病毒变异株和疫苗接种对重新安排手术时间框架的影响。
研究设计与样本
- 系统综述,于2022年3月7日系统检索PubMed(MEDLINE)、Excerpta Medica数据库和专业学会网站,共纳入14项研究和专业学会指南。
主要发现
- 无症状新型冠状病毒感染者应在检测阳性后4-8周重新安排手术,期间未出现症状。
- 轻/中度新型冠状病毒感染者应在检测阳性后6-8周且症状完全缓解后重新安排手术。
- 重/危重症新型冠状病毒感染者应在出院后至少12周且症状完全缓解后重新安排手术。
关键数值与推荐
- 无症状感染者:检测阳性后4-8周重新安排手术,期间未出现症状。
- 轻/中度感染者:检测阳性后6-8周且症状完全缓解后重新安排手术。
- 重/危重症感染者:出院后至少12周且症状完全缓解后重新安排手术。
- 推荐采用多学科和以患者为中心的方法重新安排患者手术。
临床怎么用
- 原文未据此给出具体临床操作推荐,仅复述结论:应根据症状在不同时间框架内重新安排择期关节置换手术,并推荐多学科和以患者为中心的方法。
局限性
- 需要进一步研究探讨新型新型冠状病毒变异株和疫苗接种对重新安排手术时间框架的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Coronavirus Disease 2019 (COVID-19) pandemic has caused a substantial number of patients to have their elective arthroplasty surgeries rescheduled. While it is established that patients with COVID-19 who are undergoing surgery have a significantly higher risk of experiencing postoperative complications and mortality, it is not well-known at what time after testing positive the risk of postoperative complications or mortality returns to normal. METHODS: PubMed (MEDLINE), Excerpta Medica dataBASE, and professional society websites were systematically reviewed on March 7, 2022 to identify studies and guidelines on the optimal timeframe to reschedule patients for elective surgery after preoperatively testing positive for COVID-19. Outcomes included postoperative complications such as mortality, pneumonia, acute respiratory distress syndrome, septic shock, and pulmonary embolism. RESULTS: A total of 14 studies and professional society guidelines met the inclusion criteria for this systematic review. Patients with asymptomatic COVID-19 should be rescheduled 4-8 weeks after testing positive (as long as they do not develop symptoms in the interim), patients with mild/moderate COVID-19 should be rescheduled 6-8 weeks after testing positive (with complete resolution of symptoms), and patients with severe/critical COVID-19 should be rescheduled at a minimum of 12 weeks after hospital discharge (with complete resolution of symptoms). CONCLUSIONS: Given the negative association between preoperative COVID-19 and postoperative complications, patients should have elective arthroplasty surgery rescheduled at differing timeframes based on their symptoms. In addition, a multidisciplinary and patient-centered approach to rescheduling patients is recommended. Further study is needed to examine the impact of novel COVID-19 variants and vaccination on timeframes for rescheduling surgery.
引用
- Khan IA, Zaid MB, Gold PA, et al. Making a Joint Decision Regarding the Timing of Surgery for Elective Arthroplasty Surgery After Being Infected With COVID-19: A Systematic Review. J Arthroplasty. 2022. PMID: 35533820. doi:10.1016/j.arth.2022.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。